Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | -0.57% | -5.41% | +551.77% |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 05 | Elevation Oncology, Inc. Announces Management Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 192M |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | -60M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.85
x | P/E ratio 2025 * |
-3.93
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.82% |
1 day | +0.43% | ||
1 week | -5.14% | ||
Current month | -1.13% | ||
1 month | -23.70% | ||
3 months | +20.62% | ||
6 months | +823.68% | ||
Current year | +553.63% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 49 | 21-06-16 |
Tammy Furlong
DFI | Director of Finance/CFO | - | - |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 21-05-17 |
Timothy Clackson
BRD | Director/Board Member | 58 | 20-04-30 |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.5 | -0.28% | 126 134 |
24-05-09 | 3.51 | -1.96% | 219,684 |
24-05-08 | 3.58 | +2.87% | 453,904 |
24-05-07 | 3.48 | -6.95% | 561,874 |
24-05-06 | 3.74 | +1.08% | 539,403 |
Delayed Quote Nasdaq, May 10, 2024 at 10:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+553.63% | 192M | |
+2.83% | 108B | |
+11.13% | 104B | |
+1.40% | 22.33B | |
-12.11% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.18% | 17.64B | |
+5.67% | 14.05B | |
+34.62% | 12.51B |
- Stock Market
- Equities
- ELEV Stock